InvestorsHub Logo
Followers 5
Posts 277
Boards Moderated 0
Alias Born 05/29/2011

Re: None

Saturday, 06/29/2013 1:15:57 PM

Saturday, June 29, 2013 1:15:57 PM

Post# of 80490
Rationale for TKI's in Neurogenerative Diseases...

No specific use of Pona here, but if Nilotinib and Bosutinib show activity against Alzheimer's Disease you can be sure Pona will too and likely be more potent. Anyone know of data for plasma concentrations of Pona in brain vs. blood?

http://onlinelibrary.wiley.com/doi/10.1002/emmm.201302771/pdf



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.